A time sequential study was performed to investigate the histological and ultrastructural findings of fumonisin B1-induced apoptosis in the male Sprague-Dawley rat liver. Six hours after administration of FB1, marked morphologic changes of hepatocytes included the appearance of small vacuoles along the margin of cell membrane. Twelve hours after injection of FB1, acidophilic degeneration of cells occurred, but no fragmented nucleus was evident around the centrilobular area, with few apoptotic cells. By electron microscope, the degenerated acidophilic cells revealed following changes: characteristic formation of cytoplasmic vacuoles, condensed cytoplasm, detachment from neighboring cells, and as well as margination of nuclear chromatin and swollen mitochondria with amorphous matrical deposit. The number of apoptotic cells or bodies was further enhanced at 24 hours in the vicinity of dense acidophilic cells, resulting in a marked increase over the values of control rats. Serum analysis revealed the elevation of cholesterol levels from the beginning to the end of this experiment. Morphologic data and serum findings in this study support the theory that FB1-induced alteration of membrane lipid constituents of the hepatocytes are likely to be early key events in explaining the FB1 apoptotic effect.
Animal ; Carboxylic Acids/toxicity* ; Cytokines/biosynthesis ; In Situ Nick-End Labeling ; Liver/ultrastructure ; Liver/drug effects* ; Male ; Microscopy, Electron ; Mycotoxins/toxicity* ; Organ Weight/drug effects ; Rats ; Rats, Sprague-Dawley

The metabolic transformation of the drugs containing carboxylic acid groups can lead to the formation of acyl glucuronide metabolites through catalysis by glucuronosyltransferase, and produce pro-acyl glucuronide intermediate metabolites with electronic activity. Then, protein or DNA adducts appeared after a series of non-enzyme or enzyme reactions. These adducts would change the protein activity and potentially lead to idiosyncratic and genotoxicity. In this paper, we discussed the chemical activity, drug-induced mechanisms, distribution and toxicity resulting from this metabolic activation for these drugs, and stated the status and prospects of research in this field.
Biological Transport, Active ; Biotransformation ; Carboxylic Acids ; metabolism ; toxicity ; DNA Damage ; drug effects ; Drug-Related Side Effects and Adverse Reactions ; Glucuronides ; metabolism ; toxicity ; Glucuronosyltransferase ; metabolism ; Hepatocytes ; metabolism ; Humans ; Pharmaceutical Preparations ; metabolism